189 related articles for article (PubMed ID: 9514059)
1. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity.
van Slooten HJ; van de Vijver MJ; van de Velde CJ; van Dierendonck JH
Br J Cancer; 1998 Mar; 77(5):789-96. PubMed ID: 9514059
[TBL] [Abstract][Full Text] [Related]
2. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
[TBL] [Abstract][Full Text] [Related]
3. Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas.
Sierra A; Castellsagué X; Coll T; Mañas S; Escobedo A; Moreno A; Fabra A
Int J Cancer; 1998 Apr; 79(2):103-10. PubMed ID: 9583721
[TBL] [Abstract][Full Text] [Related]
4. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
Martínez-Arribas F; Núñez-Villar MJ; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2003; 23(1B):565-8. PubMed ID: 12680147
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of apoptosis regulators in breast cancer.
Krajewski S; Krajewska M; Turner BC; Pratt C; Howard B; Zapata JM; Frenkel V; Robertson S; Ionov Y; Yamamoto H; Perucho M; Takayama S; Reed JC
Endocr Relat Cancer; 1999 Mar; 6(1):29-40. PubMed ID: 10732784
[TBL] [Abstract][Full Text] [Related]
6. Low expression of bcl-2 in Brca1-associated breast cancers.
Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X
Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356
[TBL] [Abstract][Full Text] [Related]
7. The expression of oncogenes in tumour tissues of breast carcinoma patients.
Rzymowska J; Grzybowska-Szatkowska L
Folia Histochem Cytobiol; 2001; 39 Suppl 2():93-5. PubMed ID: 11820644
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in breast cancer: relationship with other pathological parameters.
Lipponen P
Endocr Relat Cancer; 1999 Mar; 6(1):13-6. PubMed ID: 10732780
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.
De Angelis PM; Stokke T; Thorstensen L; Lothe RA; Clausen OP
Mol Pathol; 1998 Oct; 51(5):254-61. PubMed ID: 10193519
[TBL] [Abstract][Full Text] [Related]
12. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
[TBL] [Abstract][Full Text] [Related]
13. Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.
Gandhi A; Holland PA; Knox WF; Potten CS; Bundred NJ
Br J Cancer; 1998 Sep; 78(6):788-94. PubMed ID: 9743302
[TBL] [Abstract][Full Text] [Related]
14. Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells.
Majumder B; Wahle KW; Moir S; Schofield A; Choe SN; Farquharson A; Grant I; Heys SD
FASEB J; 2002 Sep; 16(11):1447-9. PubMed ID: 12205043
[TBL] [Abstract][Full Text] [Related]
15. Biological indicators of aggressiveness in T1 ductal invasive breast cancer.
Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E
Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792
[TBL] [Abstract][Full Text] [Related]
16. Relationship of p53, Bcl-2, Ki-67 index and E-cadherin expression in early invasive breast cancers with comedonecrosis as an accelerated apoptosis.
Hosaka N; Ryu T; Cui W; Li Q; Nishida A; Miyake T; Takaki T; Inaba M; Ikehara S
J Clin Pathol; 2006 Jul; 59(7):692-8. PubMed ID: 16473926
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen.
Johnston SR; MacLennan KA; Sacks NP; Salter J; Smith IE; Dowsett M
Eur J Cancer; 1994; 30A(11):1663-9. PubMed ID: 7833141
[TBL] [Abstract][Full Text] [Related]
19. Expression of Bax in relation to Bcl-2 and other predictive parameters in breast cancer.
Binder C; Marx D; Binder L; Schauer A; Hiddemann W
Ann Oncol; 1996 Feb; 7(2):129-33. PubMed ID: 8777167
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: a pathway to metastatic progression in human breast cancer.
Sierra A; Castellsagué X; Escobedo A; Lloveras B; García-Ramirez M; Moreno A; Fabra A
Int J Cancer; 2000 Mar; 89(2):142-7. PubMed ID: 10754491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
